C86.21
Enteropathy-type (intestinal) T-cell lymphoma, in remission
Clinical Classification Guidelines
Inclusion Terms
- Enteropathy associated T-cell lymphoma, in remission
Medical Intelligence & Overview
Enteropathy-type T-cell lymphoma is a rare form of cancer that affects the small intestine. When it is in remission, it means that the signs and symptoms of the disease have significantly decreased or disappeared following treatment. This condition is classified under ICD-10 code C86.21 and is closely associated with celiac disease and other enteropathies. Even in remission, ongoing medical oversight is essential to monitor for potential recurrence or complications.
Causes & Symptoms
Clinical Causes: Chronic autoimmune conditions such as celiac disease Prolonged inflammation of the small intestine Genetic predisposition influencing immune system response Environmental factors, possibly including diet and infections Immunodeficiency disorders
Key Symptoms: Persistent or recurrent abdominal pain Unintentional weight loss Chronic diarrhea or other changes in bowel movements Fatigue and weakness Swelling or tenderness in the abdomen Loss of appetite Possible signs of intestinal obstruction in some cases
Diagnostic & Treatment
Diagnosis Path: Endoscopic examination with biopsy of the affected intestinal tissue Histopathological analysis to identify abnormal T-cells Imaging studies such as CT or PET scans to assess disease extent Laboratory tests including blood counts and tests for markers of inflammation Molecular studies, if necessary, to distinguish lymphoma from other intestinal conditions
Treatment Protocols: Chemotherapy to target and destroy abnormal T-cells Targeted therapies, if applicable, based on specific disease characteristics Stem cell transplantation in certain cases to enhance remission prospects Supportive care to manage symptoms and nutritional needs Regular follow-up appointments to monitor for disease recurrence or complications
Clinical Advice & FAQs
Billing Guidance
Is C86.21 a billable ICD-10 code?
Yes, C86.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.21?
Clinical documentation must specify the nature of Enteropathy-type (intestinal) T-cell lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference